|4/AMay 19, 8:44 PM ET

Chaturvedi Pravin R 4/A

4/A · Jaguar Health, Inc. · Filed May 19, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2022-04-05
Chaturvedi Pravin R
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-04-05+10,00010,000 total
  • Award

    Restricted stock units

    2022-04-05+10,00020,000 total
    Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
  • [F3]On April 6, 2022, the reporting person filed a Form 4 that erroneously indicated that 3,333 restricted stock units had vested on April 5, 2022 and that the reporting person beneficially owned 6,666 restricted stock units following such vesting. In fact, 10,000 restricted stock units had vested on such date and the reporting person beneficially owned 20,000 restricted stock units following such vesting.

Documents

1 file
  • 4
    tm2316214-9_4aseq1.xml

    OWNERSHIP DOCUMENT